Moving Forward: AddImmune Research Continues at AGT

While AddImmune is now fully integrated with American Gene Technologies (AGT), our groundbreaking HIV research continues unchanged. The science, dedication, and progress remain constant - we've simply brought everything under the main AGT banner to streamline our efforts. Follow our ongoing work at AGT's main website.

Our Mission

Addimmune was born out of a deep sense of purpose—to bring an end to the suffering caused by HIV.

39,000,000+
people living with HIV globally
1,300,000+
new cases each year globally
SCIENCE

Pioneering a functional cure for HIV.

Our cell and gene therapy approach combines our knowledge of the HIV genome and human biology to create new opportunities to explore potential cures for HIV.

We envision a future where gene and cell therapies offer people a chance to move beyond the need for life-long treatments and finally conquer this virus."

JEFF GALVIN, CEO

Latest News